Quality control guidelines for clinical-grade human induced pluripotent stem cell lines

Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations

(2017) Florian T. Merkle et al.   NATURE

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays

(2017) Marga J. Bouma et al.   Stem Cell Reports

Molecular Obstacles to Clinical Translation of iPSCs

(2016) Natalia Tapia et al.   Cell Stem Cell

COSMIC: somatic cancer genetics at high-resolution

(2016) Simon A. Forbes et al.   NUCLEIC ACIDS RESEARCH

Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells

(2015) Daniel Paull et al.   NATURE METHODS

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

(2015) PW Andrews et al.   Regenerative Medicine

Efficient CRISPR-Cas9-Mediated Generation of Knockin Human Pluripotent Stem Cells Lacking Undesired Mutations at the Targeted Locus

(2015) Florian T. Merkle et al.   Cell Reports

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells

(2014) Peter W Andrews et al.   NATURE BIOTECHNOLOGY

Identifying Personal Genomes by Surname Inference

(2013) M. Gymrek et al.   SCIENCE

Reconsidering pluripotency tests: Do we still need teratoma assays?

(2013) Christiane Buta et al.   Stem Cell Research

Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression

(2012) Sarah N Dowey et al.   Nature Protocols

Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

(2011) Bin-Kuan Chou et al.   CELL RESEARCH

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

(2011)   NATURE BIOTECHNOLOGY

A bioinformatic assay for pluripotency in human cells

(2011) Franz-Josef Müller et al.   NATURE METHODS

Normal Human Pluripotent Stem Cell Lines Exhibit Pervasive Mosaic Aneuploidy

(2011) Suzanne E. Peterson et al.   PLoS One

Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

(2010) David T. Miller et al.   AMERICAN JOURNAL OF HUMAN GENETICS

A Call to Standardize Teratoma Assays Used to Define Human Pluripotent Cell Lines

(2010) Franz-Josef Müller et al.   Cell Stem Cell